Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Dec 06, 2024

BUY
$0.6 - $0.9 $28,733 - $43,100
47,889 New
47,889 $43,000
Q1 2024

May 15, 2024

SELL
$0.6 - $0.9 $2,392 - $3,589
-3,988 Reduced 7.69%
47,889 $43,000
Q2 2023

Aug 14, 2023

BUY
$1.08 - $1.65 $56,027 - $85,597
51,877 New
51,877 $62,000
Q2 2022

Aug 15, 2022

SELL
$0.88 - $1.87 $38,519 - $81,853
-43,772 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$1.51 - $2.2 $2,313 - $3,370
-1,532 Reduced 3.38%
43,772 $67,000
Q2 2021

Aug 16, 2021

BUY
$1.51 - $4.23 $68,409 - $191,635
45,304 New
45,304 $158,000

Others Institutions Holding CTXR

About Citius Pharmaceuticals, Inc.


  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $378M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.